Identifying Novel Targets for Epigenetic Drug Discovery & Development to Accelerate Pipeline Decision Making

Time: 9:45 am
day: Day One

Details:

  • Developing new understanding of SETD2 in multiple myeloma and DLBCL
  • Acquiring awareness of novel targets and the potential for new inhibitor development

Speakers: